Membrane News and Research

RSS

New role for cholesterol in activation of cellular signaling pathway that linked to cancer

Everyone knows that cholesterol, at least the bad kind, can cause heart disease and hardening of the arteries. Now, researchers at the University of Illinois at Chicago describe a new role for cholesterol in the activation of a cellular signaling pathway that has been linked to cancer.

15 Jul 2014

CRISPR system involved in promoting antibiotic resistance

CRISPR, a system of genes that bacteria use to fend off viruses, is involved in promoting antibiotic resistance in Francisella novicida, a close relative of the bacterium that causes tularemia.

15 Jul 2014

New research opens up potential new therapeutic targets for hard-to-treat food allergy

New research in Nature Genetics identifies a novel genetic and molecular pathway in the esophagus that causes eosinophillic esophagitis (EoE), opening up potential new therapeutic strategies for an enigmatic and hard-to-treat food allergy.

14 Jul 2014

New approach for developing personalized gene therapies to treat retinitis pigmentosa

Columbia University Medical Center researchers have created a way to develop personalized gene therapies for patients with retinitis pigmentosa (RP), a leading cause of vision loss.

11 Jul 2014

New pathway to disabling disease: blocking bacteria's access to iron in the body

In an era of increasing concern about the prevalence of antibiotic-resistant illness, Case Western Reserve researchers have identified a promising new pathway to disabling disease: blocking bacteria's access to iron in the body.

10 Jul 2014

Pathogen and ranavirus also contribute in amphibian extinctions

Amphibian declines and extinctions around the world have been linked to an emerging fungal disease called chytridiomycosis, but new research from the National Institute for Mathematical and Biological Synthesis (NIMBioS) shows that another pathogen, ranavirus, may also contribute.

10 Jul 2014

Study provides new knowledge about EphA2 receptor involved in several forms of cancer

Researchers at Karolinska Institutet in Sweden have headed a study that provides new knowledge about the EphA2 receptor, which is significant in several forms of cancer. This is important knowledge in itself - but just as important is how this study, which is published in the highly respected journal Nature Methods, was conducted.

8 Jul 2014

Headbanging to Motörhead thought to have caused bleeding in the brain

A recent report in the Lancet describes the case of a man who developed bleeding in the brain after headbanging at a Motörhead concert.

4 Jul 2014

Researchers identify pathogenic mechanism common to several neurodegenerative diseases

An international team of researchers identified a pathogenic mechanism that is common to several neurodegenerative diseases. The findings suggest that it may be possible to slow the progression of dementia even after the onset of symptoms.

4 Jul 2014

BBSRC announce launch of Crossing Biological Membranes’ network

The BBSRC, with support from EPSRC, have committed £18M to fund 13 unique collaborative Networks in Industrial Biotechnology and Bioenergy (BBSRC NIBB).

4 Jul 2014

Researchers unlock secret behind the activation of Ras proteins

A breakthrough discovery into how living cells process and respond to chemical information could help advance the development of treatments for a large number of cancers and other cellular disorders that have been resistant to therapy.

4 Jul 2014

Persons with reduced levels of TREM2 protein at greater risk for neurodegenerative diseases

Persons with reduced levels of the TREM2 protein could be at greater risk of developing neurodegenerative diseases such as Alzheimer's disease or frontotemporal dementia, according to an international study which included the participation of the Universitat Autònoma de Barcelona and the Sant Pau Biomedical Research Institute.

3 Jul 2014

Researchers discover a way to restore corneal surface

A Boston-based scientific collaborative, led by Harvard Stem Cell Institute researchers, has discovered a way to collect the best cell type for regenerating a damaged cornea-the clear membrane that covers the pupil and directs light into the back of the eye.

3 Jul 2014

Galderma's trifarotene molecule gets FDA Orphan Drug Designation for treatment of congenital ichthyosis

Galderma announces that the U.S. FDA granted Orphan Drug Designation status for the company's trifarotene molecule for the treatment of congenital ichthyosis. Based on this decision, Galderma plans to implement a clinical development plan, reinforcing its commitment to exploring new treatment options for rare diseases, as well as meeting the needs of all patients with skin diseases over the course of their lives.

2 Jul 2014

Sugar-coated cells are potentially deadly for cancer patients

Every living cell's surface has a protein-embedded membrane that's covered in polysaccharide chains - a literal sugar coating. A new study by a Cornell University researcher found this coating is especially thick and pronounced on cancer cells and is a crucial determinant of the cell's survival.

2 Jul 2014

NEI researchers describe functions of gene responsible for anchoring cilia

Researchers at the National Eye Institute (NEI) have described the functions of a gene responsible for anchoring cilia - sensory hair-like extensions present on almost every cell of the body.

2 Jul 2014

New way to combat bacterial biofilm formation with titanium encrusted with gold nanoparticles

Bacteria love to colonize surfaces inside your body, but they have a hard time getting past your rugged, salty skin.

1 Jul 2014

New concussion therapy program for NFL members

Upledger Institute Clinic in conjunction with the Ricky Williams Foundation announced today the launch of their concussion therapy pilot program aimed at treating current and former members of the NFL.

28 Jun 2014

Personalized antibiotic therapy can help fight antibiotic-resistant infections

The Centers for Disease Control and Prevention warned last fall that the U.S. faces "potentially catastrophic consequences" if it doesn't act quickly to combat the growing threat of antibiotic-resistant infections, which kill about 23,000 Americans a year.

27 Jun 2014

Biologists develop new method to investigate cell surface's organization on nanometer scale

After a ten-year effort, Prof. Dr. Michael Reth from the Institute of Biology III of the University of Freiburg and the Max Planck Institute of Immunobiology and Epigenetics has developed a method to investigate the cell surface's organization on a nanometer scale.

26 Jun 2014

Membrane News and Research

New role for cholesterol in activation of cellular signaling pathway that linked to cancer

CRISPR system involved in promoting antibiotic resistance

New research opens up potential new therapeutic targets for hard-to-treat food allergy

New approach for developing personalized gene therapies to treat retinitis pigmentosa

New pathway to disabling disease: blocking bacteria's access to iron in the body

Pathogen and ranavirus also contribute in amphibian extinctions

Study provides new knowledge about EphA2 receptor involved in several forms of cancer

Headbanging to Motörhead thought to have caused bleeding in the brain

Researchers identify pathogenic mechanism common to several neurodegenerative diseases

BBSRC announce launch of Crossing Biological Membranes’ network

Researchers unlock secret behind the activation of Ras proteins

Persons with reduced levels of TREM2 protein at greater risk for neurodegenerative diseases

Researchers discover a way to restore corneal surface

Galderma's trifarotene molecule gets FDA Orphan Drug Designation for treatment of congenital ichthyosis

Sugar-coated cells are potentially deadly for cancer patients

NEI researchers describe functions of gene responsible for anchoring cilia

New way to combat bacterial biofilm formation with titanium encrusted with gold nanoparticles

New concussion therapy program for NFL members

Personalized antibiotic therapy can help fight antibiotic-resistant infections

Biologists develop new method to investigate cell surface's organization on nanometer scale

Latest eBooks

Industry Focus eBook - Analytical Chemistry (3rd edition)

Industry Focus eBook - Microbiome (1st edition)

Industry Focus eBook - Cell biology (5th edition)

Advancing degrader and proximity-based drug development

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo